145 related articles for article (PubMed ID: 37908574)
1. An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule.
Yuang K; Al-Bahadili H; Chang A
JCEM Case Rep; 2023 May; 1(3):luad052. PubMed ID: 37908574
[TBL] [Abstract][Full Text] [Related]
2. Hürthle cell thyroid carcinoma presenting as a "hot" nodule.
Yalla NM; Reynolds LR
Endocr Pract; 2011; 17(3):e68-72. PubMed ID: 21454238
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
Mishra A; Pal L; Mishra SK
World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.
Tang Y; Meng X; Yu X; Shang H; Chen S; Liao L; Dong J
J Endocrinol Invest; 2020 Apr; 43(4):439-450. PubMed ID: 31612419
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic carcinoma and toxic multinodular goiter: an unusual presentation.
Marcelino M; Marques P; Lopes L; Leite V; de Castro JJ
Eur Thyroid J; 2014 Dec; 3(4):278-82. PubMed ID: 25759806
[TBL] [Abstract][Full Text] [Related]
6. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
Nikitski AV; Rominski SL; Condello V; Kaya C; Wankhede M; Panebianco F; Yang H; Altschuler DL; Nikiforov YE
Thyroid; 2019 Oct; 29(10):1425-1437. PubMed ID: 31298630
[No Abstract] [Full Text] [Related]
7. Toxic nodular goiter and thyroid cancer: Is hyperthyroidism protective against thyroid cancer?
Tam AA; Ozdemir D; Alkan A; Yazicioglu O; Yildirim N; Kilicyazgan A; Ersoy R; Cakir B
Surgery; 2019 Sep; 166(3):356-361. PubMed ID: 31104806
[TBL] [Abstract][Full Text] [Related]
8. A rare case of poorly differentiated thyroid carcinoma probably arising from a nodular goiter.
Yasuoka H; Nakamura Y; Hirokawa M; Yoshida KI; Anno K; Tori M; Tsujimoto M
BMC Clin Pathol; 2017; 17():9. PubMed ID: 28588422
[TBL] [Abstract][Full Text] [Related]
9. FNA diagnosis of poorly differentiated thyroid carcinoma. A review of the recent literature.
Saglietti C; Onenerk AM; Faquin WC; Sykiotis GP; Ziadi S; Bongiovanni M
Cytopathology; 2017 Dec; 28(6):467-474. PubMed ID: 29094425
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Thyroid-Stimulating Hormone Receptor Gene Mutations and/or Sodium-Iodine Symporter Gene Overexpression in Indeterminate Thyroid Fine Needle Biopsies.
Guan H; Matonis D; Toraldo G; Lee SL
Front Endocrinol (Lausanne); 2018; 9():566. PubMed ID: 30319546
[No Abstract] [Full Text] [Related]
11. High Rates of Underlying Thyroid Cancer in Patients Undergoing Thyroidectomy for Hyperthyroidism.
Alvarez AL; Mulder M; Handelsman RS; Lew JI; Farra JC
J Surg Res; 2020 Jan; 245():523-528. PubMed ID: 31450040
[TBL] [Abstract][Full Text] [Related]
12. Autonomously functioning thyroid nodule treated with radioactive iodine and later diagnosed as papillary thyroid cancer.
Uludag M; Yetkin G; Citgez B; Isgor A; Basak T
Hormones (Athens); 2008; 7(2):175-9. PubMed ID: 18477556
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated and anaplastic thyroid cancer.
Patel KN; Shaha AR
Cancer Control; 2006 Apr; 13(2):119-28. PubMed ID: 16735986
[TBL] [Abstract][Full Text] [Related]
14. A synchronous papillary and follicular thyroid carcinoma presenting as a large toxic nodule in a female adolescent.
Van Vlaenderen J; Logghe K; Schiettecatte E; Vermeersch H; Huvenne W; De Waele K; Van Beveren H; Van Dorpe J; Creytens D; De Schepper J
Int J Pediatr Endocrinol; 2020; 2020():14. PubMed ID: 32699545
[TBL] [Abstract][Full Text] [Related]
15. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
16. Insular variant of poorly differentiated thyroid carcinoma.
Fat I; Kulaga M; Dodis R; Carling T; Theoharis C; Rennert NJ
Endocr Pract; 2011; 17(1):115-21. PubMed ID: 20634178
[TBL] [Abstract][Full Text] [Related]
17. Poorly Differentiated Thyroid Carcinoma.
Setia N; Barletta JA
Surg Pathol Clin; 2014 Dec; 7(4):475-89. PubMed ID: 26837549
[TBL] [Abstract][Full Text] [Related]
18. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
Cracolici V; Cipriani NA
Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
[TBL] [Abstract][Full Text] [Related]
19. Fixed 30 mCi (1110 MBq)
Pereira LSB; Riguetto CM; Neto AM; Tambascia MA; Ramos CD; Zantut-Wittmann DE
World J Nucl Med; 2021; 20(4):349-354. PubMed ID: 35018149
[TBL] [Abstract][Full Text] [Related]
20. Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?
Wächter S; Di Fazio P; Maurer E; Manoharan J; Keber C; Pfestroff A; Librizzi D; Bartsch DK; Luster M; Eilsberger F
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
